Dr. Sergio Max Rodriguez , MD
Urology • Miami, FL
7500 Sw 8th St, Suite 304
Miami, FL 331444400
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 7, 2006; this date does not establish years in practice.
-
Published CMS data list 25 Medicare Part D prescriptions, including refills, in 2022.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022. Published rows only; this is not a quality measure.
-
Published Part D records, 2022:
- Linzess (Linaclotide) — 14 prescription fills, including refills.
- Famotidine — 11 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 1,428 in 2018 to 25 in 2022.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2018–2022.
Practice Location & Contact Primary Location
7500 Sw 8th St
Suite 304
Miami, FL 331444400
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
25 standardized 30-day fills in 2022
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$7,338 in 2022
The total cost of these prescriptions in 2022, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $17.29 in 2024
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2024.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Rodriguez are from 2022.
74 active clinicians are listed under Urology with a practice address in Miami, FL (1,021 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
45.9% of these 74 clinicians have the CMS telehealth indicator.
67.6% of these 74 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 98% from 1,428 in 2018 to 25 in 2022.
- 2018: 1,428
- 2019: 1,262
- 2020: 87
- 2021: 54
- 2022: 25
-
30-day fills
30-day fills decreased 99% from 1,882 in 2018 to 25 in 2022.
- 2018: 1,882
- 2019: 1,806
- 2020: 133
- 2021: 55
- 2022: 25
-
Part D drug cost
Part D drug cost decreased 93% from $107,838 in 2018 to $7,338 in 2022.
- 2018: $107,838
- 2019: $87,791
- 2020: $1,181
- 2021: $10,403
- 2022: $7,338
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2024 only.
Sources: CMS Medicare Part D Prescribers (2022), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): fewer than 11 records totaling $17.29.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $17.29 |
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2022.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Linzess | Linaclotide | 14 | 420 | $7,241.66 | — |
| Famotidine | Famotidine | 11 | 330 | $96.03 | — |
Source: CMS Part D by Provider and Drug, 2022; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Obstetrics & Gynecology
Doctor of Medicine (M.D.)
General Practice
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Family Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Internal Medicine
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated September 07, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Miami
- Dr. Dipen Parekh, MD
- Dr. Andrew Chi, MD
- Dr. Cosme Gomez, MD
- Dr. Daniel Martinez, MD
- Dr. Luis Maggiolo, MD
- Dr. Ahmed Eldefrawy, MD
Mailing Address
7500 Sw 8th St, Suite 304
Miami, FL 331444400
Phone: 3052663306